4//SEC Filing
PYOTT DAVID E I 4
Accession 0001735276-24-000070
CIK 0001178670other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:28 PM ET
Size
19.3 KB
Accession
0001735276-24-000070
Insider Transaction Report
Form 4
PYOTT DAVID E I
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-24$70.20/sh+7,420$520,884→ 25,116 total - Sale
Common Stock
2024-06-24$220.00/sh−17,560$3,863,200→ 15,026 total - Sale
Common Stock
2024-06-24$222.00/sh−7,470$1,658,340→ 136 total - Exercise/Conversion
Common Stock
2024-06-24$88.95/sh+17,560$1,561,962→ 17,696 total - Exercise/Conversion
Common Stock
2024-06-24$71.99/sh+7,470$537,765→ 32,586 total - Sale
Common Stock
2024-06-24$221.00/sh−7,420$1,639,820→ 7,606 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-24−7,470→ 3,780 totalExercise: $71.99From: 2018-06-02Exp: 2027-06-01→ Common Stock (7,470 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-06-24−7,420→ 3,830 totalExercise: $70.20From: 2017-06-03Exp: 2026-06-03→ Common Stock (7,420 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-06-24−17,560→ 7,440 totalExercise: $88.95Exp: 2025-12-18→ Common Stock (17,560 underlying)
Holdings
- 27,900(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023.
- [F2]The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
- [F3]This stock option was fully vested and exercisable as of June 3, 2017.
- [F4]This stock option was fully vested and exercisable as of June 2, 2018.
- [F5]This stock option was fully vested and exercisable as of December 18, 2018.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001051578
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:28 PM ET
- Size
- 19.3 KB